Challenges to I-125 Seed Localization of Metastatic Axillary Lymph Nodes Following Neoadjuvant Chemotherapy
Objective
The objective of this retrospective study is to characterize challenges with ultrasound (US)-guided localization of clipped metastatic axillary lymph nodes after neoadjuvant chemotherapy.
Methods
After institutional review board approval, our radiology database was searched for all radioactive seed localizations (RSLs), which use a low-dose radioactive isotope, Iodine-125, performed for clipped axillary lymph nodes between January 1, 2016, and December 31, 2018. The details of each procedure were reviewed. RSL was defined to be successful if US-guidance was used, and postlocalization imaging showed the seed was no more than 1 cm away from the target. Cause and subsequent management of unsuccessful localizations were documented.
Results
During the study period, 139 clipped axillary lymph nodes (in 138 women and 1 man) were scheduled for preoperative RSL. The overall success rate of RSL was 106/139 (76%). The number of unsuccessful localizations was 10/37 (27%) in 2016, 7/39 (18%) in 2017, and 16/63 (25%) in 2018, with a total unsuccessful case frequency of 33/139 (24%) over the entire study period. The mean time interval between marker placement and localization was 6.0 months (range 0.4–18.1 months). The coil biopsy marker was the most frequently used marker.
Conclusions
Preoperative US-guided I-125 seed localization of clipped metastatic axillary lymph nodes is suboptimal or unsuccessful 24% of the time. Other options for non-US imaging-guided localizations, such as tomosynthesis, are available for consideration when US detection is unsuccessful.
Top-30
Journals
|
1
2
3
4
|
|
|
Ultrasound in Medicine and Biology
4 publications, 33.33%
|
|
|
Radiology Imaging Cancer
2 publications, 16.67%
|
|
|
Journal of Breast Imaging
2 publications, 16.67%
|
|
|
American Journal of Roentgenology
1 publication, 8.33%
|
|
|
Clinical Imaging
1 publication, 8.33%
|
|
|
IEEE Transactions on Biomedical Engineering
1 publication, 8.33%
|
|
|
Translational Breast Cancer Research
1 publication, 8.33%
|
|
|
1
2
3
4
|
Publishers
|
1
2
3
4
5
|
|
|
Elsevier
5 publications, 41.67%
|
|
|
Radiological Society of North America (RSNA)
2 publications, 16.67%
|
|
|
Oxford University Press
2 publications, 16.67%
|
|
|
American Roentgen Ray Society
1 publication, 8.33%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 8.33%
|
|
|
AME Publishing Company
1 publication, 8.33%
|
|
|
1
2
3
4
5
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.